Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 3/20 | 0.51 |
| ▸ | MAPT | P10636 | 6/20 | 0.42 |
| ▸ | NPC1 | O15118 | 4/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.42 |
| ▸ | RAB9A | P51151 | 3/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.39 |
| ▸ | AHR | P35869 | 1/20 | 0.39 |
| ▸ | MBNL1 | Q9NR56 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16581049 | 0.97 | PTPN1 (0.55) | PTPN1MAPTNPC1KMT2ASMN1; SMN2 | |
| SCHEMBL16581087 | 0.91 | PTPN1 (0.52) | PTPN1MAPTNPC1KMT2ASMN1; SMN2 | |
| SCHEMBL20098009 | 0.86 | NPC1 (0.44) | PTPN1MAPTNPC1KMT2ASMN1; SMN2 | |
| SCHEMBL16581244 | 0.86 | NPC1 (0.44) | PTPN1MAPTNPC1KMT2ASMN1; SMN2 | |
| SCHEMBL20412680 | 0.85 | PTPN1 (0.50) | PTPN1MAPTNPC1KMT2ASMN1; SMN2 | |
| SCHEMBL24113970 | 0.84 | PTPN1 (0.52) | PTPN1MAPTNPC1KMT2ASMN1; SMN2 | |
| SCHEMBL16581096 | 0.84 | PTPN1 (0.43) | PTPN1MAPTNPC1KMT2ASMN1; SMN2 | |
| SCHEMBL20098007 | 0.84 | CYP2C9 (0.41) | MAPTNPC1KMT2ASMN1; SMN2RAB9A | |
| SCHEMBL16581069 | 0.82 | PTPN1 (0.64) | PTPN1MAPTNPC1KMT2ASMN1; SMN2 | |
| SCHEMBL9962632 | 0.77 | HPGD (0.59) | MAPTNPC1SMN1; SMN2RAB9AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10793555-B2 | Oxime ester photoinitiators | BASF SE (DE) | 2020-10-06 | — | — | US | disclosed |
| US-20180208583-A1 | OXIME ESTER PHOTOINITIATORS | BASF SE (DE) | 2018-07-26 | — | — | US | disclosed |
| US-9957258-B2 | Oxime ester photoinitiators | BASF SE (DE) | 2018-05-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10793555-B2 | Oxime ester photoinitiators | NR2E3, OXER1, CBR3 | PTPN1 1262/4885MAPT 4764/4885NPC1 3823/4885 |
| US-20180208583-A1 | OXIME ESTER PHOTOINITIATORS | NR2E3, OXER1, CBR3 | PTPN1 1262/4885MAPT 4764/4885NPC1 3823/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.